Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
12/2007
12/18/2007US7309718 Leukotriene D4 and E4 antagonists; antiasthmatic, antiallergic and antiinflammatory agents; oral absorbability, sustained action; such as [3-[(E)-2-(6,7-difluoroquinolin-2-yl)ethenyl]-5H-dibenzo[a,d]cyclohepten-5-yl]oxyacetic acid
12/18/2007US7309710 Crystals
12/18/2007US7309703 Substituted pyrazoles useful for treating autoimmune diseases mediated by cathepsin S
12/18/2007US7309690 Parenterally or nasally administering zinc-free immune-system-inactive thymulin peptide analogue: Glu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asp; migraine, sciatica, neuropathy and inflammatory pain
12/18/2007US7309604 Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins
12/18/2007CA2489763C Pharmaceutical salts of reboxetine
12/18/2007CA2462459C Copolymers for suppression of autoimmune diseases, and methods of use
12/18/2007CA2233042C Specific binding members for human transforming growth factor beta; materials and methods
12/13/2007WO2007143660A1 Reducing muscle soreness with glucosamine compositions
12/13/2007WO2007143294A1 Use of botulinum toxin for alleviating testicular pain
12/13/2007WO2007142924A1 Ibudilast for inhibiting macrophage migration inhibitory factor (mif) activity
12/13/2007WO2007142923A1 Mif inhibitors for treating neuropathic pain and associated syndromes
12/13/2007WO2007142577A1 Pyrrolo[3,2-d]pyrimidin-4-one derivative as myeloperoxidase inhibitor
12/13/2007WO2007142576A1 2-thioxanthine derivatives acting as mpo-inhibitors
12/13/2007WO2007142431A1 New non-peptide compounds, process for the preparation thereof and pharmaceutical composition comprising the same
12/13/2007WO2007142325A1 Preventive or remedy for inflammatory disease
12/13/2007WO2007142323A1 Novel indazole derivative having spiro ring structure in side chain
12/13/2007WO2007142304A1 SENSE OLIGONUCLEOTIDE CAPABLE OF CONTROLLING THE EXPRESSION OF iNOS AND COMPOSITION COMPRISING THE SAME
12/13/2007WO2007142303A1 Method for controlling the amount of gene product, and agent for controlling the amount of gene product
12/13/2007WO2007142096A1 Inhibitor of inducible nitric oxide synthase, beverage/food, and neutraceutical food
12/13/2007WO2007141915A1 Therapeutic agent for rheumatism
12/13/2007WO2007141285A1 Treatment of gastrointestinal disorders with cgrp-antagonists
12/13/2007WO2007141284A2 Treatment of gastrointestinal disorders with cgrp antagonists
12/13/2007WO2007140625A1 Interferon gamma polymorphisms as indicators of subject outcome in critically ill subjects
12/13/2007WO2007140613A1 Fermented milk product and use thereof
12/13/2007WO2007140611A1 Salts of trimebutine and n-desmethyl trimebutine
12/13/2007WO2007119001A3 Aminomethyl pyridine derivatives, method for preparing same and therapeutic use thereof
12/13/2007WO2007095286A3 AQUEOUS PHARMACEUTICAL FORMULATIONS OF ERβ SELECTIVE LIGANDS
12/13/2007US20070287970 Method for systemic drug delivery through the nail
12/13/2007US20070287749 Bromfenac ophthalmic formulations and methods of use
12/13/2007US20070287721 Pyrazolopyridinyl pyridine
12/13/2007US20070287715 e.g.5-(4-tert-Butylphenyl-1-(4-(2-carboxypropan-2-yloxy)phenyl)indole-2-carboxylic acid ; inhibition of the activity of microsomal prostaglandin E synthase-1, 5-lipoxygenase-activating protein (FLAP); respiratory system disorders
12/13/2007US20070287713 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
12/13/2007US20070287662 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress
12/13/2007US20070287173 Therapeutic polypeptide with prolonged shelf-life and increased half life for use in treatment of cell proliferative, cardiovascular, inflammatory and autoimmune disorders
12/13/2007US20070286916 Synbiotic Use
12/13/2007US20070286896 Therapeutic or Diagnostic Drug for Inflammatory Disease Comprising Targeting Liposome
12/13/2007US20070286861 Therapeutic antibody specific for oncostatin M for use in treatment and diagnosis of rheumatoid arthritis, juvenile onset arthritis or osteoarthritis
12/13/2007US20070286853 Diagnostics and Therapeutics for Diseases Associated with Peroxisome Proliferative Activated Receptor Delta (Ppard)
12/13/2007CA2654761A1 Interferon gamma polymorphisms as indicators of subject outcome in critically ill subjects
12/13/2007CA2654623A1 An anti-nr10/il-31ra antibody for use in preventing or treating an inflammatory disease
12/13/2007CA2654457A1 Fermented milk product and use thereof
12/13/2007CA2654048A1 Treatment of gastrointestinal disorders with cgrp antagonists
12/13/2007CA2654047A1 Cgrp antagonists
12/13/2007CA2653869A1 Salts of trimebutine and n-desmethyl trimebutine
12/13/2007CA2653774A1 2-thioxanthine derivatives acting as mpo-inhibitors
12/13/2007CA2653424A1 Novel indazole derivative having spiro ring structure in side chain
12/13/2007CA2653345A1 Ibudilast for inhibiting macrophage migration inhibitory factor (mif) activity
12/13/2007CA2636288A1 Methods of treating pain and inflammation in neuronal tissue using il-31 antagonists
12/12/2007EP1865058A1 Anti-cd-20 monoclonal antibody
12/12/2007EP1864994A1 Par-2 agonist
12/12/2007EP1864977A1 Novel cyclic compound having pyrimidinylalkylthio group
12/12/2007EP1864975A2 Novel compounds
12/12/2007EP1864675A1 Orally administered peptides to ameliorate atherosclerosis
12/12/2007EP1864665A1 Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient
12/12/2007EP1864663A1 Preventive and/or therapeutic agent for rheumatoid arthritis
12/12/2007EP1863810A1 NOVEL TETRAHYDRO-1H-PYRIDO [4,3-b] INDOLE DERIVATIVES AS CB1' RECEPTOR LIGANDS
12/12/2007EP1863794A2 Pyrimidine compounds and methods of use
12/12/2007EP1863785A1 Novel thiophene sulfoximines for treating cmplement-mediated deseases and conditions
12/12/2007EP1863782A1 2-(n-methyl-propanamine)-3-(2-naphtol) thiophene, an imputity of duloxetine hydrochloride
12/12/2007EP1863765A1 6, 7, 8, 9-tetrahydro-5-amino-5h-benzocyclohepten-6-ol derivatives and related compounds used as anti-inflammatory agents
12/12/2007EP1863753A2 Trihydroxy polyunsaturated eicosanoid derivatives
12/12/2007EP1863534A1 Composition comprising a combined thromboxane receptor antagonist and thromboxane synthase inhibitor and a cox-2 inhibitor
12/12/2007EP1863514A2 Therapeutic use of scin, a staphylococcal complement inhibitor in inflammatory diseases
12/12/2007EP1863480A1 Compounds having immunomodulator activity
12/12/2007EP1863471A1 Use of angelic acid esters as an antiphlogistic active ingredient and antiphlogistic preparations
12/12/2007EP1718602A4 Therapeutic and carrier molecules
12/12/2007EP1532250B1 Fcyriia transgenic animal model for autoimmune disease
12/12/2007EP1309618B1 Leucine-based motif and clostridial neurotoxins
12/12/2007EP1295601A4 Pharmaceutical composition based on a non-steroid anti-inflammatory agent
12/12/2007EP1268481B1 Kinase inhibitors as therapeutic agents
12/12/2007EP1144454B1 Modified peptides as therapeutic agents
12/12/2007EP1143943B1 USE OF p53 INHIBITORS FOR THE TREATMENT OF SIDE EFFECTS OF CANCER THERAPY
12/12/2007EP0894130B1 Modulators of tnf receptor associated factor (traf), their preparation and use
12/12/2007EP0888377B1 MURINE alpha(1,3)-FUCOSYLTRANSFERASE (Fuc-TVII)
12/12/2007EP0819123B1 1,3-dihydro-1-(phenylalkenyl)-2h-imidazol-2-one derivatives having pde iv and cytokine inhibiting activity
12/12/2007EP0769967B1 Conjugates comprising an antitumour agent and their use
12/12/2007EP0723555B1 Chimeric proteins which block complement activation
12/12/2007CN101087773A Inhibitors of c-fms kinase
12/12/2007CN101085802A Method for preparing Notoginsen triterpenes
12/12/2007CN101085795A 金银花提取物,其制备方法和应用 Honeysuckle extract, its preparation method and application
12/12/2007CN101085336A Traditional Chinese medicine for curing dysmenorrheal and preparation method thereof
12/12/2007CN101085335A Traditional Chinese medicine decoction for treating dysmenorrhea
12/12/2007CN101085327A Traditional Chinese medicine cutaneous permeable agent
12/12/2007CN101085326A Medicine for treating rheumatoid arthritis and preparing method thereof
12/12/2007CN101085305A Vein relaxing plaster for curing cervical vertebra and lumbar vertebra disease
12/12/2007CN101085304A Plaster mainly for curing cervical vertebra and lumbar vertebra disease
12/12/2007CN101085300A Plaster for treating hyperosteogeny and pain, and its preparation method
12/12/2007CN101085267A Medicine for treating chronic rheumatic arthritis and its preparation method
12/12/2007CN101085239A Internal-applied traditional Chinese medicinal composition for treating allergic purpura
12/12/2007CN101085235A Medicine for treating acute rheumatic arthritis and preparation method thereof
12/12/2007CN101085230A Medicine for treating rheumatoid and rheumatoid oarthritis and its preparation method
12/12/2007CN101085223A Medicine for treating rheumatism and rheumatoid disease
12/12/2007CN101085222A Plaster for relieving pain
12/12/2007CN101085221A Medicine for treating common cold and preparation method thereof
12/12/2007CN101085209A Medicine for treating dysmenorrhoea and preparation method thereof
12/12/2007CN101085201A Medicine for treating common cold and preparation method thereof
12/12/2007CN101085162A Chinese medicinal herb reducing agent for treating rheumatic heart disease
12/12/2007CN101085161A Medicine for treating acute lumbar sprain and preparation method thereof
12/12/2007CN101085144A Traditional Chinese medicine composition for treating dysmenorrhoea
1 ... 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 ... 1272